Net worth context from calculable public holdings
For net-worth context, Grizzly Bulls can currently identify and value $1.6M in Lloyd Minor's supported SEC-disclosed public-company holdings.
This figure is not a complete personal net-worth estimate. Exact total net worth is not publicly known. This estimate reflects only supported direct public-company holdings that Grizzly Bulls can currently identify and value from SEC filings. It may omit private assets, liabilities, indirect holdings, and unsupported securities.
- Supported public holdings
- $1.6M
- Positions included
- 2
- Source filings
- 2
- Position knowledge through
- Oct 10, 2026
Latest SEC-reported relationship
Director at Caris Life Sciences, Inc.
Reported in an ownership filing filed Aug 14, 2026. This is filing relationship evidence, not a claim that the role or ownership relationship remains current today.
Other recent SEC-reported relationships
- Director at BIOGEN INC. · filed Aug 5, 2026
SEC evidence snapshot
The current profile contains 2 supported positions across 2 public companies, backed by 2 distinct SEC filings.
The largest included position is Caris Life Sciences, Inc. at $943.6K, or about 60.9% of the supported public-holdings total.
The latest filing represented was filed Aug 14, 2026. Current values use 1 supported valuation date across the included positions.
Supported holdings composition
Share of the supported disclosed public-holdings value above, grouped by SEC issuer. This is not a chart of total net worth or overall portfolio diversification.
Caris Life Sciences, Inc.$943.6K · 60.9%
BIOGEN INC.$606.9K · 39.1%
Current disclosed public-company holdings
These are supported direct positions traced to SEC ownership filings. Share counts use the current supported share basis, while each value uses the valuation date shown below.
| Company | Security | Current basis units | Current value | Position reported | Valuation date | SEC source |
|---|
Nasdaq:CAI | Common Stock, $0.001 par value | 31,813 | $943,573.58 | Aug 14, 2026 | Oct 9, 2026 | Form 4 Filed Aug 14, 2026 0002038687-26-000007 |
Nasdaq:BIIB | Common Stock, $0.0005 par value | 2,689 | $606,866.97 | Aug 4, 2026 | Oct 9, 2026 | Form 4 Filed Aug 5, 2026 0000875045-26-000076 |
Latest filing represented: Aug 14, 2026. The table includes 2 distinct SEC filings.
